Researcher – Professor Hing Leung
Institution - University of Glasgow
Grant award - £463,460
Reference – PG14-009-TR2

Hing leung

In a nutshell

This project addresses whether adding statins to hormone treatment will improve treatment response in hormone resistant disease, and whether any new tests can track how well the cancer is responding.

Why we funded it

This project could provide an avenue to use statins and hormone manipulation in patients with lethal prostate cancer where standard hormone treatment tends not to work well. If successful, the information from this study will inform a larger clinical trial with the end-goal to make this routine clinical practice for patients with hormone resistant prostate cancer. The researchers also plan to identify a new tracking device for monitoring the response to this treatment.

Progress so far…

Over the last 12 months the researchers have been setting up the study so that it can start to recruit patients. They’ve developed a case report form and a database to help them to collect the patient data from the trial. The study protocol is finalised and they now have the regulatory approvals that they need for the trial to take place. In the coming year the researchers will be focussing on recruiting patients to the trial.

Download digital versions of this research summary